Copeptin and Peroxiredoxin-4 Independently Predict Mortality in Patients With Nonspecific Complaints Presenting to the Emergency Department
about
Risk factors and screening instruments to predict adverse outcomes for undifferentiated older emergency department patients: a systematic review and meta-analysis.Risk stratification in emergency patients by copeptinCirculating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.Peroxiredoxin 4: a multifunctional biomarker worthy of further exploration.The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency departmentSerum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28).Physician's first clinical impression of emergency department patients with nonspecific complaints is associated with morbidity and mortalityAdrenomedullin for Risk Stratification of Emergency Patients With Nonspecific Complaints: An Interventional Multicenter Pilot Study.Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality.Drug-related emergency department visits by elderly patients presenting with non-specific complaints.Blood levels of copeptin on admission predict outcomes in out-of-hospital cardiac arrest survivors treated with therapeutic hypothermiaThe prognostic value of copeptin in patients with acute chest pain.Targeting antioxidant enzyme expression as a therapeutic strategy for ischemic stroke.Plasma concentrations of copeptin, C-reactive protein and procalcitonin are positively correlated with APACHE II scores in patients with sepsis.Correlates of diagnostic accuracy in patients with nonspecific complaints.Stress markers predict mortality in patients with nonspecific complaints presenting to the emergency department and may be a useful risk stratification tool to support disposition planning.Prevalence, characteristics and outcome of non-cardiac chest pain and elevated copeptin levels.
P2860
Q27687772-A80C801A-F207-47BE-A5A1-FC66AFCAA024Q33740059-8A7208D5-6840-404B-B1E4-5A4A4EA4FF06Q33990767-CFF58045-21E0-4556-B396-CBDB84A3DED2Q34111306-0EF13D2D-EF17-44AB-A333-45C8B3CC58BEQ34134378-6D89785A-D02E-485D-BA7E-AEE9C8F64EE5Q35107954-1EB4C8E5-1DD5-436D-B0DB-1F4BA674A6DEQ36009545-D8CF23F3-36F7-418A-88BD-4EC7DAD90E2BQ36445043-3E57070F-2A99-4A03-9E79-6E74911FD358Q36522598-7E75819F-FDC5-4492-9E84-8A42115CFCE8Q36697847-7DBD1633-3792-48C8-9D4E-BF2F86CEB3AAQ36928204-E60634AD-37A9-4582-85EC-F2FD0ADD6073Q38253152-8A2A7B13-69CB-401B-9ADF-5002F99B9FFAQ39065047-F242A43E-4E86-464C-BC72-221EED09CFFEQ41477861-8F14FE68-7421-4ECE-B048-04B7062AD933Q44320082-0584491D-5D09-4BEB-98AE-545E6C1481F1Q45222877-051D0A9C-2C2C-417C-BB47-B3F782D482ACQ48693596-077F9A8E-18D8-4004-B90A-055A30B3A2DC
P2860
Copeptin and Peroxiredoxin-4 Independently Predict Mortality in Patients With Nonspecific Complaints Presenting to the Emergency Department
description
scientific article published on 01 August 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2011
@uk
name
Copeptin and Peroxiredoxin-4 I ...... ng to the Emergency Department
@en
Copeptin and Peroxiredoxin-4 I ...... ng to the Emergency Department
@nl
type
label
Copeptin and Peroxiredoxin-4 I ...... ng to the Emergency Department
@en
Copeptin and Peroxiredoxin-4 I ...... ng to the Emergency Department
@nl
prefLabel
Copeptin and Peroxiredoxin-4 I ...... ng to the Emergency Department
@en
Copeptin and Peroxiredoxin-4 I ...... ng to the Emergency Department
@nl
P2093
P2860
P1476
Copeptin and peroxiredoxin-4 i ...... ng to the emergency department
@en
P2093
Christian H Nickel
Franziska Misch
Janin Schulte
Juliane Ruedinger
Katharina Blume
Oliver Hartmann
Silke Maile
Sven Giersdorf
P2860
P304
P356
10.1111/J.1553-2712.2011.01126.X
P577
2011-08-01T00:00:00Z